FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2286636633> ?p ?o ?g. }

• W2286636633 endingPage "53" @default.
• W2286636633 startingPage "46" @default.
• W2286636633 abstract "Dendritic cell (DC)-based immunotherapy has promising for treatment of non-small cell lung cancer (NSCLC). Melanoma-associated antigen 3 (MAGE-A3) is a tumor-specific antigen and expressed in approximately 35–40% of NSCLC tissues. Calreticulin (CALR) is a protein chaperone and can enhance DC maturation and antigen presentation. In this study, we evaluated the adjuvant activity of CALR in human DC maturation and their capacity to induce MAGE-A3-specific CD8+ cytotoxic T lymphocyte (CTL) responses to NSCLC in vitro. Infection with recombinant Ad-CALR and/or Ad-MAGE-A3, but not with control Ads, induced CALR and/or MAGE-A3 expression in DCs. Infection with Ad-CALR significantly increased the percentages of CD80+, CD83+, CD86+ and HLA-DR+ DCs and IL-12 secretion, but reduced IL-10 production in DCs. Co-culture of autologous lymphocytes with DC-Ad-CALR or DC-Ad-CM significantly increased the numbers of induced CD8+ CTLs. The percentages of IFNγ-secreting CTLs responding to SK-LU-1 and NCI-H522 NSCLC, but not to non-tumor NL-20 cells in Ad-C-CTL, Ad-M-CTL and Ad-CM-CTL were significantly higher than that of DC-CTL and Ad-null-CTL. Ad-C-CTL, Ad-M-CTL and Ad-CM-CTL, but not control DC-CTL and Ad-null-CTL, induced higher frequency of MAGE-A3+HLA-A2+ NCI-H-522 cell apoptosis, but did not affect the survival of MAGE-A3+HLA-A2- SK-LU-1 and non-tumor NL20 cells in vitro. Treatment with anti-HLA-I antibody, but not with anti-HLA-II, dramatically diminished the cytotoxicity of Ad-CM-CTLs against NCI-H522 cells. Our data indicated that CALR acted as an adjuvant to promote DC maturation, which induced CTL development and enhanced MAGE-A3-specific CTL cytotoxicity against NSCLC." @default.
• W2286636633 created "2016-06-24" @default.
• W2286636633 creator A5004000135 @default.
• W2286636633 creator A5023363049 @default.
• W2286636633 creator A5035035773 @default.
• W2286636633 creator A5042732771 @default.
• W2286636633 creator A5066402600 @default.
• W2286636633 creator A5071455942 @default.
• W2286636633 creator A5073479463 @default.
• W2286636633 creator A5083626954 @default.
• W2286636633 date "2016-02-01" @default.
• W2286636633 modified "2023-10-09" @default.
• W2286636633 title "Calreticulin acts as an adjuvant to promote dendritic cell maturation and enhances antigen-specific cytotoxic T lymphocyte responses against non-small cell lung cancer cells" @default.
• W2286636633 cites W1579417540 @default.
• W2286636633 cites W1594325464 @default.
• W2286636633 cites W1944166248 @default.
• W2286636633 cites W1990772742 @default.
• W2286636633 cites W2002952328 @default.
• W2286636633 cites W2006741811 @default.
• W2286636633 cites W2010263122 @default.
• W2286636633 cites W2016612145 @default.
• W2286636633 cites W2018092044 @default.
• W2286636633 cites W2026763255 @default.
• W2286636633 cites W2036651654 @default.
• W2286636633 cites W2044835625 @default.
• W2286636633 cites W2050216284 @default.
• W2286636633 cites W2062967876 @default.
• W2286636633 cites W2063044697 @default.
• W2286636633 cites W2064243369 @default.
• W2286636633 cites W2074756139 @default.
• W2286636633 cites W2098677932 @default.
• W2286636633 cites W2100302724 @default.
• W2286636633 cites W2108090759 @default.
• W2286636633 cites W2113614442 @default.
• W2286636633 cites W2116058268 @default.
• W2286636633 cites W2123311867 @default.
• W2286636633 cites W2131638796 @default.
• W2286636633 cites W2135238715 @default.
• W2286636633 cites W2143458560 @default.
• W2286636633 cites W2147402069 @default.
• W2286636633 cites W2151054296 @default.
• W2286636633 cites W2154063368 @default.
• W2286636633 cites W2156769579 @default.
• W2286636633 cites W2163252162 @default.
• W2286636633 cites W2172066208 @default.
• W2286636633 cites W2234552425 @default.
• W2286636633 doi "https://doi.org/10.1016/j.cellimm.2015.12.003" @default.
• W2286636633 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26702740" @default.
• W2286636633 hasPublicationYear "2016" @default.
• W2286636633 type Work @default.
• W2286636633 sameAs 2286636633 @default.
• W2286636633 citedByCount "28" @default.
• W2286636633 countsByYear W22866366332016 @default.
• W2286636633 countsByYear W22866366332017 @default.
• W2286636633 countsByYear W22866366332018 @default.
• W2286636633 countsByYear W22866366332019 @default.
• W2286636633 countsByYear W22866366332020 @default.
• W2286636633 countsByYear W22866366332021 @default.
• W2286636633 countsByYear W22866366332022 @default.
• W2286636633 countsByYear W22866366332023 @default.
• W2286636633 crossrefType "journal-article" @default.
• W2286636633 hasAuthorship W2286636633A5004000135 @default.
• W2286636633 hasAuthorship W2286636633A5023363049 @default.
• W2286636633 hasAuthorship W2286636633A5035035773 @default.
• W2286636633 hasAuthorship W2286636633A5042732771 @default.
• W2286636633 hasAuthorship W2286636633A5066402600 @default.
• W2286636633 hasAuthorship W2286636633A5071455942 @default.
• W2286636633 hasAuthorship W2286636633A5073479463 @default.
• W2286636633 hasAuthorship W2286636633A5083626954 @default.
• W2286636633 hasConcept C147483822 @default.
• W2286636633 hasConcept C147969180 @default.
• W2286636633 hasConcept C154317977 @default.
• W2286636633 hasConcept C158617107 @default.
• W2286636633 hasConcept C167672396 @default.
• W2286636633 hasConcept C202751555 @default.
• W2286636633 hasConcept C203014093 @default.
• W2286636633 hasConcept C2776090121 @default.
• W2286636633 hasConcept C2777701055 @default.
• W2286636633 hasConcept C2778170410 @default.
• W2286636633 hasConcept C2778297628 @default.
• W2286636633 hasConcept C2781101188 @default.
• W2286636633 hasConcept C39347974 @default.
• W2286636633 hasConcept C47450691 @default.
• W2286636633 hasConcept C502942594 @default.
• W2286636633 hasConcept C55493867 @default.
• W2286636633 hasConcept C86803240 @default.
• W2286636633 hasConcept C8891405 @default.
• W2286636633 hasConcept C95444343 @default.
• W2286636633 hasConceptScore W2286636633C147483822 @default.
• W2286636633 hasConceptScore W2286636633C147969180 @default.
• W2286636633 hasConceptScore W2286636633C154317977 @default.
• W2286636633 hasConceptScore W2286636633C158617107 @default.
• W2286636633 hasConceptScore W2286636633C167672396 @default.
• W2286636633 hasConceptScore W2286636633C202751555 @default.
• W2286636633 hasConceptScore W2286636633C203014093 @default.
• W2286636633 hasConceptScore W2286636633C2776090121 @default.
• W2286636633 hasConceptScore W2286636633C2777701055 @default.
• W2286636633 hasConceptScore W2286636633C2778170410 @default.

• next